(Q53580895)

English

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

scientific article published on 26 December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

0 references

0 references

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

author name string

Sakiko Ohga

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Kenichi Shikata

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Kosuke Yozai

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Shinichi Okada

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Daisuke Ogawa

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Hitomi Usui

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Yasushi Shikata

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Hirofumi Makino

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

publication date

26 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

292

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

F1141-50

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Aldose reductase and the role of the polyol pathway in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Transcription factor-kappa B (NF-kappa B) and renal disease.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Involvement of NF-kappaB in high glucose-induced alteration of alpha-methyl-D-glucopyranoside (alpha-MG) uptake in renal proximal tubule cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00288.2005

21 January 2018

Identifiers

10.1152/AJPRENAL.00288.2005

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17190910

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53580895&oldid=847755591"